Document ID: chunk:federal_register_of_legislation:F2024L01530:schedule:1
Version: federal_register_of_legislation:F2024L01530
Segment Type: schedule
Provision Reference: sch 1
Character Range: 2033–2784

Schedule 1—Amendments

National Health (Listed Drugs on F1 or F2) Determination 2021 (PB 33 of 2021)

 1.         Schedule 1, after item dealing with Abemaciclib
    Omit:
         Abiraterone

 1.         Schedule 1, after item dealing with Atezolizumab
    Omit:
         Atovaquone

 1.         Schedule 1, after item dealing with Beclometasone
    Insert:
         Belzutifan

 1.         Schedule 1, after item dealing with Dexamfetamine
    Insert:
         Dienogest

 1.         Schedule 2, after item dealing with Abatacept
    Insert:
         Abiraterone

 1.         Schedule 2, after item dealing with Atomoxetine
    Insert:
         Atovaquone

 1.         Schedule 2, after item dealing with Cefazolin
    Omit:
         Cefepime